MoonLake Immunotherapeutics (MLTX) Technical Analysis

🔺 Technical Setup

📊 Technical Summary

MoonLake Immunotherapeutics (MLTX) finished the session at 16.38 (+1.68%). With price below both the 50-day and 200-day moving averages, the broader structure still reflects elevated technical pressure. 20-day momentum is running at -0.85%, with price is trading in the lower part of its roughly 52-week range (6.24–61.99), while ATR14 volatility is elevated at roughly 5.08% of price. RSI(14) is 42.8, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. From a pattern perspective, the main active signal is Double top. Nearby upside pressure sits around 17.22. A decisive move through that level would improve the short-term picture. On the fundamentals side, the latest snapshot shows Net income: -70.69M · EPS (basic): -1.10. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more